Global Market for Label-Free Detection
Dublin, June 20, 2023 (GLOBE NEWSWIRE) -- The "Label-Free Detection: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Label-Free Detection estimated at US$1.1 Billion in the year 2022, is projected to reach a revised size of US$1.9 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2022-2030.
Instruments, one of the segments analyzed in the report, is projected to record 6.3% CAGR and reach US$1.3 Billion by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Consumables segment is readjusted to a revised 8% CAGR for the next 8-year period.
The U.S. Market is Estimated at $386 Million, While China is Forecast to Grow at 8.9% CAGR
The Label-Free Detection market in the U.S. is estimated at US$386 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$171.9 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.5% and 6.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.
Select Competitors (Total 41 Featured) -
-
Agilent Technologies, Inc.
-
AMETEK, Inc.
-
Attana AB
-
Corning Inc.
-
Hitachi High-Technologies Corp.
-
Horiba Ltd.
-
Malvern Panalytical Ltd.
-
PerkinElmer, Inc.
-
Thermo Fisher Scientific, Inc.
-
Danaher Corporation
-
Molecular Devices, LLC
-
AB SCIEX
-
GE Healthcare Life Sciences
-
TA Instruments
-
Merck KGaA.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 384 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $1.1 Billion |
| Forecasted Market Value (USD) by 2030 | $1.9 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
-
Influencer Market Insights
-
World Market Trajectories
-
Growing Population, Rising Disease Burden, the Need for New Generation Drugs & Rising Pharma R&D, the Cornerstone for Growth in the Market
-
Rising Prevalence of Chronic Diseases Amplifies the Need for Advancing Healthcare Research: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
-
Aging Population Burdens an Already Strained Healthcare System: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
-
Robust Investments in Lifesciences Research to Develop Effective, Safe & Affordable Drugs Spurs Growth in the Pharmaceutical & Biotechnology Sectors
-
Better Insights Offered by Label-Free Detection into Drug Binding Kinetics & Drug Residence Time Drives Demand for this Technology in Drug Discovery: Global Pharma R&D Spending (In US$ Billion) for the Years 2017, 2019, 2022 & 2024
-
Growing Interest in Genomics Research: A Major Win for the Market
-
A Strong Vision for the Future of Genomics Creates Robust Demand for Improved Repertoire of Research Tools: Global Market for Genomics (In US$ Billion) for the Years 2019, 2022, 2024 & 2026
-
A Review of Key Market Segments
-
Label-Free Detection - Global Key Competitors Percentage Market Share in 2022 (E)
-
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
-
Impact of Covid-19 and a Looming Global Recession